142 related articles for article (PubMed ID: 35380227)
21. Preoperative prediction of central lymph node metastasis in thyroid papillary microcarcinoma using clinicopathologic and sonographic features.
Kim KE; Kim EK; Yoon JH; Han KH; Moon HJ; Kwak JY
World J Surg; 2013 Feb; 37(2):385-91. PubMed ID: 23073506
[TBL] [Abstract][Full Text] [Related]
22. Gray-scale ultrasonography combined with elastography imaging for the evaluation of papillary thyroid microcarcinoma: as a prognostic clinicopathology factor.
Jin ZQ; Lin MY; Hu WH; Li WY; Bai SJ
Ultrasound Med Biol; 2014 Aug; 40(8):1769-77. PubMed ID: 24768485
[TBL] [Abstract][Full Text] [Related]
23. Impact of major different variants of papillary thyroid microcarcinoma on the clinicopathological characteristics: the study of 1041 cases.
Zhi J; Zhao J; Gao M; Pan Y; Wu J; Li Y; Li D; Yu Y; Zheng X
Int J Clin Oncol; 2018 Feb; 23(1):59-65. PubMed ID: 28744725
[TBL] [Abstract][Full Text] [Related]
24. Clinical and Pathologic Predictors of Lymph Node Metastasis and Recurrence in Papillary Thyroid Microcarcinoma.
Siddiqui S; White MG; Antic T; Grogan RH; Angelos P; Kaplan EL; Cipriani NA
Thyroid; 2016 Jun; 26(6):807-15. PubMed ID: 27117842
[TBL] [Abstract][Full Text] [Related]
25. Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence.
Feng JW; Ye J; Wu WX; Qu Z; Qin AC; Jiang Y
J Endocrinol Invest; 2020 Dec; 43(12):1807-1817. PubMed ID: 32557354
[TBL] [Abstract][Full Text] [Related]
26. Predicting the factors associated with central lymph node metastasis in clinical node-negative (cN0) papillary thyroid microcarcinoma.
Zhang C; Li BJ; Liu Z; Wang LL; Cheng W
Eur Arch Otorhinolaryngol; 2020 Apr; 277(4):1191-1198. PubMed ID: 31932880
[TBL] [Abstract][Full Text] [Related]
27. Clinical implications of microscopic extrathyroidal extension in patients with papillary thyroid carcinoma.
Park JS; Chang JW; Liu L; Jung SN; Koo BS
Oral Oncol; 2017 Sep; 72():183-187. PubMed ID: 28222967
[TBL] [Abstract][Full Text] [Related]
28. Ultrasound assessment of degrees of extrathyroidal extension in papillary thyroid microcarcinoma.
Moon SJ; Kim DW; Kim SJ; Ha TK; Park HK; Jung SJ
Endocr Pract; 2014 Oct; 20(10):1037-43. PubMed ID: 24793922
[TBL] [Abstract][Full Text] [Related]
29. Minimal extrathyroidal extension in patients with papillary thyroid microcarcinoma: is it a real prognostic factor?
Moon HJ; Kim EK; Chung WY; Yoon JH; Kwak JY
Ann Surg Oncol; 2011 Jul; 18(7):1916-23. PubMed ID: 21267788
[TBL] [Abstract][Full Text] [Related]
30. Prediction of central lymph node metastasis in patientswith thyroid papillary microcarcinoma.
Akın Ş; Yazgan Aksoy D; Akın S; Kılıç M; Yetişir F; Bayraktar M
Turk J Med Sci; 2017 Dec; 47(6):1723-1727. PubMed ID: 29306230
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for lymph node metastasis (LNM) in patients with papillary thyroid microcarcinoma (PTMC): role of preoperative ultrasound.
Zhao C; Jiang W; Gao Y; Niu W; Zhang X; Xin L
J Int Med Res; 2017 Jun; 45(3):1221-1230. PubMed ID: 28534700
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathologic Factors and Thyroid Nodule Sonographic Features for Predicting Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Retrospective Study of 1204 Patients.
Wang WH; Xu SY; Zhan WW
J Ultrasound Med; 2016 Nov; 35(11):2475-2481. PubMed ID: 27794131
[TBL] [Abstract][Full Text] [Related]
33. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
[TBL] [Abstract][Full Text] [Related]
34. Prediction of cervical lymph node metastases in papillary thyroid microcarcinoma by sonographic features of the primary site.
Wei X; Wang M; Wang X; Zheng X; Li Y; Pan Y; Li Y; Mu J; Yu Y; Li D; Gao M; Zhang S
Cancer Biol Med; 2019 Aug; 16(3):587-594. PubMed ID: 31565487
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of the relationship between ultrasonographic features and cervical lymph node skip metastasis of papillary thyroid micro-carcinoma].
Wang XQ; Wei X; Xu Y; Wang HL; Xin XJ; Zhang S
Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):373-377. PubMed ID: 31137172
[No Abstract] [Full Text] [Related]
36. Risk Factors of Metastatic Lymph Nodes in Papillary Thyroid Microcarcinoma.
Ruiz Pardo J; Ríos A; Rodríguez JM; Paredes M; Soriano V; Oviedo MI; Hernández AM; Parrilla P
Cir Esp (Engl Ed); 2020 Apr; 98(4):219-225. PubMed ID: 31980154
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
[TBL] [Abstract][Full Text] [Related]
38. Clinical impact of microscopic extrathyroidal extension in patients with papillary thyroid microcarcinoma treated with hemithyroidectomy.
Ahn D; Sohn JH; Jeon JH; Jeong JY
J Endocrinol Invest; 2014 Feb; 37(2):167-73. PubMed ID: 24497215
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.
Mercante G; Frasoldati A; Pedroni C; Formisano D; Renna L; Piana S; Gardini G; Valcavi R; Barbieri V
Thyroid; 2009 Jul; 19(7):707-16. PubMed ID: 19348581
[TBL] [Abstract][Full Text] [Related]
40. The relationship between lipotoxicity and risk of extrathyroidal extension in papillary thyroid microcarcinoma.
Li C; Guan H; He Q; Zhao Y; Liang N; Zhang J; Dionigi G; Sun H
Endocrine; 2021 Dec; 74(3):646-657. PubMed ID: 34189681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
